Viatris | VTRS - Stammkapital

Aktienkurs
17.26
Täglich Wechseln
-0.11 -0.63%
Monatlich
24.53%
Jährlich
96.36%
Q2 Prognose
16.81




Stammkapital Veränderung Datum
Celltrion KRW 218.61M 162.21K 2025-12
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Kangmei Pharma CNY 13.83B 34.97M 2025-09
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pharma Mar EUR 17.36M 0 2026-03
Qiagen NV USD 216.56M 284.67K 2025-12
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 5.27M 2026-03
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03